Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA delay
Biotech
FDA delays decision on Biohaven troriluzole filing, plans adcomm
Forty-eight hours after saying its filing was on track, the biopharma revealed the FDA has delayed a decision on its rare disease drug troriluzole.
Nick Paul Taylor
May 15, 2025 6:02am
FDA misses PDUFA date for Stealth’s ultra-rare disease candidate
Apr 30, 2025 9:00am
FDA delays decision on Merus' first-in-class cancer drug
Nov 5, 2024 9:14am
FDA demands data on 2 PTC candidates, delaying filing
Oct 27, 2023 7:30am
FDA resource constraints delay decision on Iovance cell therapy
Sep 15, 2023 5:20am
FDA delays decision on Valneva's chikungunya vaccine by 3 months
Aug 14, 2023 6:00am